We are excited! Three new members have joined to Astherna team! Berno Maaswinkel (CEO), Erwin van Wijk (Associate Professor in Genetics) and Irene Vázquez Domínguez (post-doctoral researcher) joined our team 1st April 2023. They will complement the current team expertise. Berno as a CEO will lead the company, Erwin will focus on the development of an RNA treatment for Usher syndrome while Irene will be focused on pre-clinical testing.